Two new preventative Covid trials get government funding

Two new clinical trials to develop treatments to prevent people catching Covid-19 are getting underway in the UK.

The government-funded trials will evaluate prophylactic treatments for Covid-19 in care homes and for those with compromised immune systems.

The PROTECT-V trial, run by the University of Cambridge, will look at the effectiveness of potential Covid-19 treatments in reducing the spread of the virus amongst immunocompromised groups. It launched this month and will last at least 12 months.

There are at least 500,000 people who could benefit from these treatments in England alone, and 2,250 are expected to take part in the trial.

The PROTECT-CH trial, run by the University of Nottingham, will also look at treatments for reducing transmission and serious illness from the virus, for care home residents and staff. The trial will begin in May 2021 and last around 2 years. It aims to recruit more than 400 care homes to take part, covering approximately 12,000 elderly residents.

Comments (0)

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.